+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dysmenorrhea"

From
Hormonal Contraceptives Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Hormonal Contraceptives Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Dysmenorrhea Market Report and Forecast 2024-2032 - Product Thumbnail Image

Dysmenorrhea Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Endometriosis - Epidemiology Forecast to 2030 - Product Thumbnail Image

Endometriosis - Epidemiology Forecast to 2030

  • Report
  • December 2021
  • 44 Pages
  • Global
From
From
Loading Indicator

Dysmenorrhea, also known as painful periods, is a common condition experienced by women during menstruation. It is characterized by cramping, abdominal pain, and other symptoms such as nausea, vomiting, and diarrhea. Dysmenorrhea can range from mild to severe and can have a significant impact on a woman's quality of life. Treatment options for dysmenorrhea include lifestyle modifications, medications, and alternative therapies. The dysmenorrhea market is an important part of the women's health industry. It is estimated that up to 90% of women experience some form of dysmenorrhea, making it a major concern for many. Companies in the dysmenorrhea market are focused on providing treatments and solutions to help women manage their symptoms. These include pharmaceutical companies, medical device manufacturers, and healthcare providers. Some of the companies in the dysmenorrhea market include Bayer AG, Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, and Allergan plc. These companies offer a variety of products and services to help women manage their dysmenorrhea symptoms. Show Less Read more